Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
VOYDEYA™ approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular hemolysis in adults with the rare disease PNH
-
Moving iMage Technologies (MiT) Announces Stock Repurchase Program and 10b5-1 Stock Trading Plan
-
GoldenTree Asset Management Announces $1.3 Billion in Commitments for Third CLO Equity Fund
-
Cathedra Bitcoin Announces Fourth Quarter and Full-Year 2023 Financial Results
-
NMG Pays Accrued Interests and Grants Options
-
Greenland Technologies Operations Unaffected by Francis Scott Key Bridge Collapse in Baltimore, MD; Company Reaffirms April 2024 Sales Delivery Plan
-
DecisionPoint Systems Announces Fourth Quarter and Full Year 2023 Results
-
Dillard’s Launches Caelynn Bell for Gianni Bini
-
BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS
-
Schuman Cheese Wins Award for World's Best Parmesan for Third Consecutive Year
-
Edible Garden Reports 21.6% Year-over-Year Revenue Growth for 2023
-
Antibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance
-
Boston Trust Walden Announces Portfolio Manager Responsibility Changes
-
Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results
-
Guess?, Inc. Announces Issuance of Approximately $12.1 Million of Additional 3.75% Convertible Notes Due 2028 and Retirement of Approximately $14.6 Million of Existing 2.00% Convertible Notes Due 2024
-
Stericycle Receives a B Rating on Third CDP Climate Change Survey
-
Guess?, Inc. Board Authorizes New $200 Million Share Repurchase Program
-
Aurora Cannabis Commends Germany's Landmark Legalization Achievement
-
Selina Announces Updates to Its Executive Leadership Team
-
Novocure to Report First Quarter 2024 Financial Results
-
Plaskolite Names Michael Gilbert President and CEO
-
Papa Johns to Report 2024 First Quarter Results on May 9, 2024
-
Turbine and Harmonic Discovery Pair Simulation-Guided Biology and Multi-Target Kinase Inhibition Chemistry Expertise to Develop a Novel Cancer Therapy
-
Bruker Selected as ‘Company of the Year’ by Instrument Business Outlook
-
Walser Launches 4-Day Work Week Prioritizing Flexibility, Customer Experience
-
Atlantic Union Bankshares Corporation Completes Acquisition of American National Bankshares Inc.
-
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
-
Bitfarms Announces March 2024 Production and Operations Update
-
LogRhythm Unveils Advanced Capabilities for Cloud-Native SIEM Platform, LogRhythm Axon
-
Digihost Announces 60% Month-Over-Month Increase in Cash and Crypto Position and Provides March 2024 Production Update
-
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
-
Venus Concept Announces Fourth Quarter and Fiscal Year 2023 Financial Results
-
Selina Releases New Investor Presentation for the Investment Community
-
Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
-
Enthusiast Gaming Advances Strategic Objectives with C$4.1 Million Sale of Select Non-Core Assets
-
Telesat and Government of Canada Agree to Terms on C$2.14 Billion Loan in Support of Telesat Lightspeed
-
Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder
-
Institutional Investors Express Support For Trian’s Candidates at Disney
-
Autolus Therapeutics Announces Changes to its Board of Directors
-
Advisory: Chevron Corporation’s 1Q 2024 Earnings Conference Call and Webcast
-
The Scotts Miracle-Gro Foundation and Doodles and Digits Partner to Bring "How It's Math" to Public Television
-
Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Oatly to Report First Quarter 2024 Financial Results on April 30, 2024
-
Apellis Pharmaceuticals to Host a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
-
The Scotts Miracle-Gro Foundation and Doodles and Digits Partner to Bring "How It's Math" to Public Television
-
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference
-
Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States
-
Mammoth Holdings Opens PureMagic Carwash in Greater Knoxville, TN
-
Sachem Capital Corp. Announces Dividend of $0.11 Per Share

